Global Pleuritis Market, By Diagnostic Type (Thoracentesis, Imaging Devices, Blood Test, and Others), Treatment Type (Antibiotics, Antifungals, Blood Thinners, Nonsteroidal Anti-Inflammatory Drugs, and Others), End User (Hospital, Clinics, Diagnostics Laboratories, and Others), Mode of Purchase (Prescription and Over the Counter), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Others), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights: Global Pleuritis Disease Market
Global Pleuritis market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market is growing at a CAGR of 4.70% in the above-mentioned research forecast period.
Pleuritis or pleurisy is a rare condition in which the pleura – becomes inflamed and swollen. Pleurisy causes chest pain, which deteriorates during breathing. If a person is suffering from pleuritis, the two layers of the pleural membrane rub against each other, which causes pain when a person inhales and exhales. However, if the person holds the breath, then the chronic pleuritic pain decreases. The signs and symptoms of pleuritis are fever, cough, shortness of breath. Pleural effusion is when the fluid gets accumulated in small air vacuoles between two layers of tissue. Empyema, results in the accumulation of infected fluid, hence resulting in the formation of pus. The condition is followed by fever. The other causes observed are tuberculosis, autoimmune disorder (rheumathoid arthritis), fungal, bacterial infection, viral infection, rib fracture.
Pleuritis can be diagnosed by chest X-rays, blood tests, thoracentesis, ultrasound, biopsy, CT scan, thoracoscopy. Pleuritis can be cured by lying on the side, which has pain, can provide enough pressure to make the pain away. Other methods are the use of antibiotics, prescribed pain and cough medication, bronchodilators via metered-dose inhaler devices, such as those used to treat asthma, aspirin, ibuprofen and other non-steroidal anti-inflammatory drugs. Unless the patient does not seek medical treatment on time, the patient can have chronic long-term implications.
The rise in the geriatric population, increased chronic lung disorders and pneumonia, investment by R&D in pharmaceutical companies, increased demand for antibiotics and NSAIDS and lack of healthy lifestyle are predicted to drive the market growth. However, the lack of health remuneration policies, increased expenses for treatment, lack of proper sanitation, side effects associated with the use of antibiotics are expected to hinder the market growth. The rise of emerging markets in developing countries, the rise of untapped opportunities, upcoming healthcare diagnostic laboratories, and upcoming modifications in diagnostic machines are the opportunities that are projected to bolster the market growth. The lack of expertise, rise in the product (antibiotic) recalls, and use of alternatives other than antibiotics are the challenges that can hamper the market growth.
This pleuritis market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Global Pleuritis Market Scope and Market Size
The pleuritis market is segmented on the basis of diagnostic device, treatment type, route of administration, end user, mode of purchase and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of type, the pleuritis market is segmented into thoracentesis, video-assisted thoracic surgery, blood test, and others.
- On the basis of treatment type, the pleuritis market is segmented into antibiotics, antifungals, blood thinners, nonsteroidal anti-inflammatory drugs, and others.
- On the basis of end user, the pleuritis market is segmented into hospital, clinics, diagnostics laboratories, and others.
- On the basis of mode of purchase, the pleuritis market is segmented into prescription, OTC
- On the basis of distribution channel, the pleuritis market has also been segmented into hospital pharmacies, retail pharmacies, online pharmacies and others.
Pleuritis Market Country Level Analysis
Pleuritis market is analysed and market size information is provided by country, disease, drugs, drug type, dosage, end-users and distribution channel as referenced above.
The countries covered in the pleuritis market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.
On geographical estimation, North America is expected to hold the largest market share due to the rise in government initiatives, increased healthcare expenditure, and rise in cases of pneumonia and lung cancer. 2.56 million People succumbed due to pneumonia in 2017. In 2017, 221, 121 new cases of lung cancer were diagnosed. Europe is also expected to become the fastest growing market, due to the availability of funds and increased awareness about the diagnosis and treatment for pleuritis. Asia-Pacific is also expected to account for the second largest market share due to the maximum cases of lung disorders, rise in point of care diagnostics, untapped opportunities in emerging markets, and rise of healthcare facilities. However, Middle East and Africa is expected to show negative growth in the market due to less research and inadequate healthcare facilities.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Pleuritis market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Pleuritis Market Share Analysis
Pleuritis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to pleuritis market.
The major players covered in the pleuritis market are Scanlan International, Sontec Instruments, Teleflex Incorporated, Integra LifeSciences Corporation, Olympus Corporation, Delacroix-Chevalier, Myra and Co, Wexler Surgical, Hoffmann-La Roche Ltd, Novartis AG, Pfizer, Merck KGaA, Bristol-Myers Squibb Company, Eli Lilly and Company, and Sanofi among other domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-